Trgovina Natera, Inc. - NTRA CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Pogoji trgovanja
| Razmik | - | ||||||||
|
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.024068% | ||||||||
|
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.001846% | ||||||||
| Čas nočne pristojbine | 21:00 (UTC) | ||||||||
| Min. tržena količina | 1 | ||||||||
| Valuta | USD | ||||||||
| Kritje | 20% | ||||||||
| Borza | United States of America | ||||||||
| Provizija na trgovanje | 0% |
*Information provided by Capital.com
Ključni statistični podatki
| Predhodno. Zapri* | N/A |
| Odpri* | N/A |
| Enoletna sprememba* | N/A |
| Dnevni razpon* | N/A |
| Razpon 52 wk | 27.35-59.75 |
| Povprečni obseg (10 dni) | 1.51M |
| Povprečni obseg (3 meseci) | 28.39M |
| Tržna kapitalizacija | 6.42B |
| Razmerje P/E | -100.00K |
| Število delnic v obtoku | 113.29M |
| Prihodki | 820.22M |
| EPS | -5.57 |
| Dividenda (donosnost v %) | N/A |
| Beta | 1.20 |
| Datum naslednjega zaslužka | May 3, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
|---|
Natera, Inc. Events
| Čas (UTC) (UTC) | Država | Dogodek |
|---|---|---|
| No events scheduled | ||
- Letni
- Četrtletno
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Skupni prihodki | 625.486 | 391.005 | 302.328 | 257.654 | 209.625 |
| Prihodki | 625.486 | 391.005 | 302.328 | 257.654 | 209.625 |
| Celotni stroški prihodkov | 318.418 | 203.62 | 175.47 | 166.055 | 139.596 |
| Bruto dobiček | 307.068 | 187.385 | 126.858 | 91.599 | 70.029 |
| Celotni odhodki iz poslovanja | 1093.66 | 613.13 | 418.615 | 372.282 | 344.966 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 511.034 | 303.627 | 204.476 | 154.872 | 155.306 |
| Raziskave in razvoj | 264.208 | 100.035 | 51.357 | 51.355 | 50.064 |
| Prihodki iz poslovanja | -468.174 | -222.125 | -116.287 | -114.628 | -135.341 |
| Prihodki (odhodki) od obresti, neto Neoperativni | -8.305 | -15.082 | -10.693 | -10.476 | -4.213 |
| Drugo, neto | 5.381 | 7.562 | 4.152 | -2.729 | 2.38 |
| Čisti dobiček pred obdavčitvijo | -471.098 | -229.645 | -122.828 | -127.833 | -137.174 |
| Čisti dobiček po davkih | -471.716 | -229.743 | -124.827 | -128.154 | -137.628 |
| Čisti dobiček pred dodatnimi postavkami | -471.716 | -229.743 | -124.827 | -128.154 | -137.628 |
| Čisti dobiček | -471.716 | -229.743 | -124.827 | -128.154 | -137.628 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -471.716 | -229.743 | -124.827 | -128.154 | -137.628 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -471.716 | -229.743 | -124.827 | -128.154 | -137.628 |
| Popravljen čisti dobiček | -471.716 | -229.743 | -124.827 | -128.154 | -137.628 |
| Popravljene ponderirane povprečne delnice | 90.558 | 81.011 | 69.555 | 57.848 | 53.312 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -5.20899 | -2.83595 | -1.79465 | -2.21536 | -2.58156 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
| Popravljen normalizirani dobiček na enoto čistega dobička | -5.20899 | -2.78903 | -1.91322 | -2.21536 | -2.58156 |
| Skupaj izredne postavke | 0 | ||||
| Nenavadni odhodki (prihodki) | 0 | 5.848 | -12.688 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Skupni prihodki | 194.133 | 173.028 | 158.116 | 142.026 | 152.316 |
| Prihodki | 194.133 | 173.028 | 158.116 | 142.026 | 152.316 |
| Celotni stroški prihodkov | 103.215 | 94.122 | 81.371 | 76.112 | 66.813 |
| Bruto dobiček | 90.918 | 78.906 | 76.745 | 65.914 | 85.503 |
| Celotni odhodki iz poslovanja | 331.263 | 312.694 | 308.313 | 257.32 | 215.333 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 147.634 | 146.761 | 128.485 | 127.456 | 108.332 |
| Raziskave in razvoj | 80.414 | 71.811 | 98.457 | 53.752 | 40.188 |
| Prihodki iz poslovanja | -137.13 | -139.666 | -150.197 | -115.294 | -63.017 |
| Prihodki (odhodki) od obresti, neto Neoperativni | -2.087 | -2.079 | -2.078 | -2.075 | -2.073 |
| Drugo, neto | 0.801 | 1.151 | 1.274 | 1.585 | 1.371 |
| Čisti dobiček pred obdavčitvijo | -138.416 | -140.594 | -151.001 | -115.784 | -63.719 |
| Čisti dobiček po davkih | -138.595 | -140.564 | -151.273 | -116.026 | -63.853 |
| Čisti dobiček pred dodatnimi postavkami | -138.595 | -140.564 | -151.273 | -116.026 | -63.853 |
| Čisti dobiček | -138.595 | -140.564 | -151.273 | -116.026 | -63.853 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -138.595 | -140.564 | -151.273 | -116.026 | -63.853 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -138.595 | -140.564 | -151.273 | -116.026 | -63.853 |
| Popravljen čisti dobiček | -138.595 | -140.564 | -151.273 | -116.026 | -63.853 |
| Popravljene ponderirane povprečne delnice | 95.578 | 94.842 | 92.558 | 88.077 | 86.689 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -1.45007 | -1.48209 | -1.63436 | -1.31732 | -0.73658 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Popravljen normalizirani dobiček na enoto čistega dobička | -1.45007 | -1.48209 | -1.63436 | -1.31732 | -0.73658 |
| Nenavadni odhodki (prihodki) | 0 | 0 | 0 |
- Letni
- Četrtletno
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 1093.14 | 862.663 | 523.167 | 240.518 | 180.625 |
| Denarna sredstva in kratkoročne naložbe | 914.282 | 737.274 | 440.991 | 153.868 | 118.867 |
| Denarna sredstva in ustrezniki | 84.386 | 48.668 | 61.926 | 46.407 | 12.62 |
| Kratkoročne naložbe | 829.896 | 688.606 | 379.065 | 107.461 | 106.247 |
| Celotne terjatve, neto | 122.074 | 78.565 | 53.351 | 62.223 | 44.089 |
| Accounts Receivable - Trade, Net | 122.074 | 78.565 | 53.351 | 62.223 | 44.089 |
| Total Inventory | 26.909 | 20.031 | 12.394 | 13.633 | 8.998 |
| Prepaid Expenses | 29.645 | 26.606 | 16.376 | 6.197 | 8.612 |
| Other Current Assets, Total | 0.228 | 0.187 | 0.055 | 4.597 | 0.059 |
| Total Assets | 1236.49 | 932.153 | 582.656 | 268.171 | 214.613 |
| Property/Plant/Equipment, Total - Net | 124.529 | 54.747 | 47.013 | 24.336 | 29.667 |
| Property/Plant/Equipment, Total - Gross | 143.942 | 104.801 | 88.537 | 58.633 | 56.652 |
| Accumulated Depreciation, Total | -19.413 | -50.054 | -41.524 | -34.297 | -26.985 |
| Other Long Term Assets, Total | 18.82 | 14.743 | 12.476 | 3.317 | 4.321 |
| Total Current Liabilities | 218.956 | 199.053 | 179.874 | 113.981 | 105.561 |
| Accounts Payable | 27.206 | 8.096 | 8.604 | 14.587 | 8.529 |
| Accrued Expenses | 114.854 | 71.689 | 54.03 | 33.843 | 35.558 |
| Notes Payable/Short Term Debt | 50.052 | 50.054 | 50.123 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 50.153 | 50.112 | |||
| Other Current Liabilities, Total | 26.844 | 69.214 | 67.117 | 15.398 | 11.362 |
| Total Liabilities | 583.183 | 445.917 | 303.945 | 236.009 | 189.196 |
| Total Long Term Debt | 280.394 | 202.493 | 73.656 | 73.357 | 73.065 |
| Other Liabilities, Total | 83.833 | 44.371 | 50.415 | 48.671 | 10.57 |
| Total Equity | 653.304 | 486.236 | 278.711 | 32.162 | 25.417 |
| Preferred Stock - Non Redeemable, Net | 0 | ||||
| Common Stock | 0.01 | 0.009 | 0.008 | 0.007 | 0.006 |
| Additional Paid-In Capital | 2050.42 | 1411.29 | 976.955 | 607.236 | 472.552 |
| Retained Earnings (Accumulated Deficit) | -1394.84 | -929.318 | -699.171 | -574.529 | -446.375 |
| Other Equity, Total | -2.287 | 4.259 | 0.919 | -0.552 | -0.766 |
| Total Liabilities & Shareholders’ Equity | 1236.49 | 932.153 | 582.656 | 268.171 | 214.613 |
| Total Common Shares Outstanding | 95.14 | 86.223 | 78.005 | 62.083 | 54.04 |
| Long Term Debt | 280.394 | 202.493 | 73.656 | 73.357 | 73.065 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 980.226 | 1093.14 | 1191.22 | 739.888 | 791.403 |
| Denarna sredstva in kratkoročne naložbe | 751.958 | 914.282 | 1023.7 | 580.243 | 653.572 |
| Denarna sredstva in ustrezniki | 158.298 | 84.386 | 95.103 | 62.811 | 65.126 |
| Kratkoročne naložbe | 593.66 | 829.896 | 928.596 | 517.432 | 588.446 |
| Celotne terjatve, neto | 167.862 | 122.074 | 110.416 | 100.13 | 87.562 |
| Accounts Receivable - Trade, Net | 167.862 | 122.074 | 110.416 | 100.13 | 87.562 |
| Total Inventory | 25.048 | 26.909 | 28.022 | 28.409 | 23.676 |
| Prepaid Expenses | 35.13 | 29.645 | 28.858 | 30.878 | 26.43 |
| Other Current Assets, Total | 0.228 | 0.228 | 0.228 | 0.228 | 0.163 |
| Total Assets | 1144.66 | 1236.49 | 1311.37 | 849.956 | 893.512 |
| Property/Plant/Equipment, Total - Net | 142.762 | 124.529 | 106.949 | 97.221 | 89.703 |
| Property/Plant/Equipment, Total - Gross | 165.177 | 143.942 | 165.263 | 152.538 | 142.306 |
| Accumulated Depreciation, Total | -22.415 | -19.413 | -58.314 | -55.317 | -52.603 |
| Other Long Term Assets, Total | 21.676 | 18.82 | 13.202 | 12.847 | 12.406 |
| Total Current Liabilities | 231.072 | 218.956 | 199.714 | 197.988 | 166.969 |
| Accounts Payable | 18.07 | 27.206 | 8.181 | 20.307 | 4.682 |
| Accrued Expenses | 130.919 | 114.854 | 114.18 | 93.183 | 81.711 |
| Notes Payable/Short Term Debt | 50.055 | 50.052 | 50.049 | 50.049 | 50.052 |
| Other Current Liabilities, Total | 32.028 | 26.844 | 27.304 | 34.449 | 30.524 |
| Total Liabilities | 602.329 | 583.183 | 552.357 | 550.846 | 521.067 |
| Total Long Term Debt | 280.706 | 280.394 | 280.085 | 279.777 | 279.471 |
| Long Term Debt | 280.706 | 280.394 | 280.085 | 279.777 | 279.471 |
| Other Liabilities, Total | 90.551 | 83.833 | 72.558 | 73.081 | 74.627 |
| Total Equity | 542.335 | 653.304 | 759.017 | 299.11 | 372.445 |
| Common Stock | 0.01 | 0.01 | 0.01 | 0.009 | 0.009 |
| Additional Paid-In Capital | 2089.66 | 2050.42 | 2011.79 | 1399.66 | 1356.21 |
| Retained Earnings (Accumulated Deficit) | -1533.43 | -1394.84 | -1254.27 | -1103 | -986.973 |
| Other Equity, Total | -13.904 | -2.287 | 1.491 | 2.441 | 3.197 |
| Total Liabilities & Shareholders’ Equity | 1144.66 | 1236.49 | 1311.37 | 849.956 | 893.512 |
| Total Common Shares Outstanding | 96.259 | 95.14 | 94.538 | 88.498 | 87.43 |
- Letni
- Četrtletno
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Čisti prihodki/začetna postavka | -471.716 | -229.743 | -124.827 | -128.154 | -137.628 |
| Denarna sredstva iz poslovanja | -335.236 | -182.512 | -63.444 | -70.581 | -97.825 |
| Denarna sredstva iz poslovanja | 11.254 | 8.613 | 7.73 | 7.501 | 7.143 |
| Nedenarne postavke | 171.299 | 77.748 | 26.452 | 22.916 | 13.05 |
| Cash Taxes Paid | 0.283 | 0.067 | 2.154 | 0.332 | 0.177 |
| Denarna sredstva Plačane obresti | 7.077 | 3.296 | 12.455 | 7.914 | 3.568 |
| Spremembe v obratnem kapitalu | -46.073 | -39.13 | 27.201 | 27.156 | 19.61 |
| Denarna sredstva pri naložbenju | -205.193 | -331.461 | -266.353 | -5.161 | 13.784 |
| Kapitalski izdatki | -49.588 | -19.604 | -4.968 | -3.88 | -9.867 |
| Celotne druge postavke denarnih tokov pri naložbenju | -155.605 | -311.857 | -261.385 | -1.281 | 23.651 |
| Denarna sredstva pri financiranju | 576.188 | 500.847 | 340.774 | 113.725 | 80.372 |
| Izdaja (odplačilo) delnic, neto | 576.188 | 301.288 | 340.774 | 113.725 | 5.659 |
| Izdaja (odplačilo) dolga, neto | 0 | 199.559 | 0 | 0 | 75 |
| Neto sprememba denarnih sredstev | 35.759 | -13.126 | 10.977 | 37.983 | -3.669 |
| Postavke denarnega toka pri financiranju | 0 | -0.287 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -138.595 | -471.716 | -331.152 | -179.879 | -63.853 |
| Cash From Operating Activities | -137.277 | -335.236 | -236.5 | -145.439 | -74.876 |
| Cash From Operating Activities | 3.002 | 11.254 | 8.259 | 5.262 | 2.549 |
| Non-Cash Items | 40.865 | 171.299 | 136.312 | 68.849 | 28.676 |
| Cash Interest Paid | 0.159 | 7.077 | 3.69 | 3.538 | 0.152 |
| Changes in Working Capital | -42.549 | -46.073 | -49.919 | -39.671 | -42.248 |
| Cash From Investing Activities | 207.033 | -205.193 | -284.697 | 146.709 | 86.74 |
| Capital Expenditures | -15.885 | -49.588 | -36.298 | -18.891 | -10.26 |
| Other Investing Cash Flow Items, Total | 222.918 | -155.605 | -248.399 | 165.6 | 97 |
| Cash From Financing Activities | 4.156 | 576.188 | 567.673 | 12.914 | 4.57 |
| Issuance (Retirement) of Stock, Net | 4.156 | 576.188 | 567.673 | 12.914 | 4.57 |
| Net Change in Cash | 73.912 | 35.759 | 46.476 | 14.184 | 16.434 |
| Issuance (Retirement) of Debt, Net | 0 | 0 | 0 |
| Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
|---|---|---|---|---|---|---|
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.7594 | 9923131 | 1628200 | 2022-12-31 | LOW |
| Fred Alger Management, LLC | Investment Advisor/Hedge Fund | 7.9205 | 8972823 | 191477 | 2022-12-31 | MED |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.2045 | 4763130 | 715214 | 2022-12-31 | LOW |
| Samlyn Capital, LLC | Hedge Fund | 3.8755 | 4390372 | 2113236 | 2022-12-31 | HIGH |
| JP Morgan Asset Management | Investment Advisor | 3.739 | 4235761 | 101390 | 2022-12-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 3.1533 | 3572262 | 764812 | 2022-12-31 | LOW |
| Sofinnova Investments, Inc | Venture Capital | 2.7369 | 3100560 | -2400 | 2022-12-31 | MED |
| Citadel Advisors LLC | Hedge Fund | 2.6914 | 3048948 | 884865 | 2022-12-31 | HIGH |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.4544 | 2780428 | 1886903 | 2022-12-31 | LOW |
| Eversept Partners, LP | Hedge Fund | 2.371 | 2685959 | 1260357 | 2022-12-31 | MED |
| RTW Investments L.P. | Investment Advisor/Hedge Fund | 2.3033 | 2609283 | 400000 | 2022-12-31 | LOW |
| Kynam Capital Management LP | Hedge Fund | 2.2979 | 2603207 | 584847 | 2022-12-31 | HIGH |
| Principal Global Investors (Equity) | Investment Advisor | 1.7724 | 2007860 | 867205 | 2022-12-31 | LOW |
| OrbiMed Advisors, LLC | Investment Advisor/Hedge Fund | 1.7181 | 1946353 | 441200 | 2022-12-31 | LOW |
| Avidity Partners Management LP | Hedge Fund | 1.5879 | 1798900 | 63900 | 2022-12-31 | HIGH |
| Pictet Asset Management Ltd. | Investment Advisor/Hedge Fund | 1.5711 | 1779828 | 184128 | 2022-12-31 | LOW |
| Braidwell LP | Hedge Fund | 1.4309 | 1621012 | 1621012 | 2022-12-31 | |
| D. E. Shaw & Co., L.P. | Hedge Fund | 1.3493 | 1528566 | -53493 | 2022-12-31 | MED |
| Marshall Wace LLP | Investment Advisor/Hedge Fund | 1.3171 | 1492125 | 262940 | 2022-12-31 | HIGH |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.3059 | 1479376 | 217067 | 2022-12-31 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group500K+
Borzni posredniki
92K+
Aktivne stranke mesečno
$53M+
Mesečni obseg naložb
$30M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
Trgovalna provizija
0
- 1:1
Vzvod
1:1
- 20
- 100
- 500
- 1000
- 10000
Naložbe
Velikost posla (finančni vzvod x naložba):
Odpiranje
Zapiranje
Kratka Dolga
Natera, Inc. Company profile
O družbi Natera, Inc.
Natera, Inc. je diagnostično podjetje. Osredotoča se na razvoj in trženje storitev molekularnega testiranja z uporabo svoje tehnologije na področju zdravja žensk, onkologije in zdravja organov. Tehnologija brezcelične DNK (cfDNA) družbe združuje njene molekularne teste, ki zanesljivo merijo številne informativne regije v genomu iz vzorcev, ki so tako majhni kot ena celica. Družba ponuja naslednje izdelke: neinvazivni prenatalni test Panorama (NIPT), Vistara, Horizon Carrier Screening (HCS), Spectrum Pre-implantacijska genetika (Spectrum), Anora Miscarriage Test (Anora), neinvazivni test očetovstva (PAT) in Prospera. Podjetje ponuja tudi programsko platformo v oblaku Constellation, ki laboratorijskim strankam omogoča dostop do algoritmov in bioinformatike podjetja v oblaku za potrjevanje in uvajanje testov, ki temeljijo na tehnologiji podjetja.
| Industry: | Laboratory Diagnostic & Testing Substances |
13011 Mccallen Pass
Building A Suite 100
AUSTIN
TEXAS 78753
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 500.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com